SCHEMBL30936699

SCHEMBL30936699

CN(c1ccc(F)cc1N)C1CCCCC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
KCNH2 Q12809 1/20 0.40
IDO1 P14902 2/20 0.39
GAA P10253 2/20 0.39
HTT P42858 2/20 0.39
JAK1 P23458 4/20 0.38
JAK3 P52333 4/20 0.38
JAK2 O60674 2/20 0.38
KDM4E B2RXH2 1/20 0.38
DDB1 Q16531 1/20 0.38
CRBN Q96SW2 1/20 0.38
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
NOS3 P29474 2/20 0.36
NOS1 P29475 2/20 0.36
NOS2 P35228 2/20 0.36
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
PDE3B Q13370 1/20 0.35
PDE3A Q14432 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1242072 0.83 DDB1 (0.52) ALDH1A1KCNH2IDO1GAAHTT
SCHEMBL30936610 0.82 KMT2A (0.54) ALDH1A1GAAHTTJAK1JAK3
SCHEMBL16538261 0.82 ALDH1A1 (0.42) ALDH1A1KCNH2GAAHTTJAK1
SCHEMBL739596 0.81 PSEN1 (0.41) ALDH1A1KCNH2IDO1GAAJAK1
SCHEMBL8564451 0.77 GAA (0.41) ALDH1A1GAAJAK1JAK3JAK2
SCHEMBL1136265 0.76 HTT (0.56) ALDH1A1KCNH2IDO1HTTKDM4E
SCHEMBL30936629 0.75 LMNA (0.40) ALDH1A1GAAJAK1JAK3JAK2
SCHEMBL29157521 0.75 DDB1 (0.55) ALDH1A1IDO1HTTDDB1CRBN
SCHEMBL28076318 0.74 GAA (0.55) ALDH1A1GAAHTTMAPTSLC6A2
SCHEMBL11622509 0.73 SLC6A2 (0.52) ALDH1A1KCNH2HTTJAK3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250340510-A1 Substituted Phenylbenzenesulfonamide Derivatives and Uses Thereof NINE SQUARE THERAPEUTICS CORPORATION (US) 2025-11-06 US disclosed
EP-4608389-A2 SUBSTITUTED PHENYLBENZENESULFONAMIDE DERIVATIVES AND USES THEREOF Nine Square Therapeutics Corporation (US) 2025-09-03 EP disclosed
WO-2024092235-A2 SUBSTITUTED PHENYLBENZENESULFONAMIDE DERIVATIVES AND USES THEREOF NINE SQUARE THERAPEUTICS CORPORATION (US) 2024-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250340510-A1 Substituted Phenylbenzenesulfonamide Derivatives and Uses Thereof TRPM2, TRPM6, TRPM5 ALDH1A1 3137/4885KCNH2 400/4885IDO1 3538/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.